Donald A. Denkhaus, Director at NOVEN PHARMACEUTICALS INC (NOVN), bought 10,000 shares at $10.90 ($109K) on 2008-05-15, disclosed to the SEC on 2008-05-19.
Open-market purchase of $109k NOVN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.89 | 1,900 | $21K | 19.0% |
| 2 | $10.90 | 8,100 | $88K | 81.0% |
| Total | $10.90 avg | 10,000 | $109K | 100% |
| Filing → |
| CPRX | BUY | 2018-12-28 | $48K | — | Filing → |
| CPRX | BUY | 2018-12-17 | $149K | — | Filing → |
| CPRX | BUY | 2018-06-11 | $68K | — | Filing → |